Thailand’s Public Health Minister Anutin Charnvirakul said on Friday the country planned to develop the anti-viral pill molnupiravir to combat Covid-19 infections amid rising infections driven by the Omicron coronavirus variant.
The molnupiravir Covid-19 treatment pill for adult patients at risk of developing severe illness was jointly developed by US-based Merck & Co Inc and Ridgeback Biotherapeutics.
The Southeast Asian nation intends to join other countries in the region also planning to make versions of the drug, including Bangladesh and India.
“For molnupiravir, the…